These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 16008557
1. Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells. de Bock CE, Lin Z, Itoh T, Morris D, Murrell G, Wang Y. FEBS J; 2005 Jul; 272(14):3572-82. PubMed ID: 16008557 [Abstract] [Full Text] [Related]
2. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. Karikó K, Kuo A, Boyd D, Okada SS, Cines DB, Barnathan ES. Cancer Res; 1993 Jul 01; 53(13):3109-17. PubMed ID: 8391387 [Abstract] [Full Text] [Related]
3. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A. Exp Cell Res; 2004 Sep 10; 299(1):91-100. PubMed ID: 15302576 [Abstract] [Full Text] [Related]
4. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM. Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945 [Abstract] [Full Text] [Related]
7. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth. Lakka SS, Gondi CS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Rao JS. Cancer Res; 2003 May 15; 63(10):2454-61. PubMed ID: 12750266 [Abstract] [Full Text] [Related]
8. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression. Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T. BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015 [Abstract] [Full Text] [Related]
9. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor. Henic E, Sixt M, Hansson S, Høyer-Hansen G, Casslén B. Gynecol Oncol; 2006 Apr 20; 101(1):28-39. PubMed ID: 16263158 [Abstract] [Full Text] [Related]
10. Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C. Velusamy T, Shetty P, Bhandary YP, Liu MC, Shetty S. Biochemistry; 2008 Jun 17; 47(24):6508-17. PubMed ID: 18494499 [Abstract] [Full Text] [Related]
11. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor. Han B, Nakamura M, Zhou G, Ishii A, Nakamura A, Bai Y, Mori I, Kakudo K. Int J Oncol; 2006 Apr 17; 28(4):807-14. PubMed ID: 16525628 [Abstract] [Full Text] [Related]
12. A urokinase receptor mRNA binding protein-mRNA interaction regulates receptor expression and function in human pleural mesothelioma cells. Shetty S, Idell S. Arch Biochem Biophys; 1998 Aug 15; 356(2):265-79. PubMed ID: 9705217 [Abstract] [Full Text] [Related]
13. Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines. Lakka SS, Rajagopal R, Rajan MK, Mohan PM, Adachi Y, Dinh DH, Olivero WC, Gujrati M, Ali-Osman F, Roth JA, Yung WK, Kyritsis AP, Rao JS. Clin Cancer Res; 2001 Apr 15; 7(4):1087-93. PubMed ID: 11309361 [Abstract] [Full Text] [Related]
14. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma. Bhuvarahamurthy V, Schroeder J, Kristiansen G, Roigas J, Denkert C, Johannsen M, Lein M, Loening SA, Schnorr D, Jung K, Staack A. Oncol Rep; 2005 Sep 15; 14(3):777-82. PubMed ID: 16077991 [Abstract] [Full Text] [Related]
15. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R, Schaaf A. Int J Oncol; 2009 Jan 15; 34(1):15-23. PubMed ID: 19082473 [Abstract] [Full Text] [Related]
16. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer. Saldanha RG, Xu N, Molloy MP, Veal DA, Baker MS. J Proteome Res; 2008 Nov 15; 7(11):4792-806. PubMed ID: 18808175 [Abstract] [Full Text] [Related]
17. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. He Y, Liu XD, Chen ZY, Zhu J, Xiong Y, Li K, Dong JH, Li X. Clin Cancer Res; 2007 Jun 01; 13(11):3115-24. PubMed ID: 17545513 [Abstract] [Full Text] [Related]
18. [The inhibitory effect of asODNs on the invasion of colorectal cancer cell line CCL229]. Jin YJ, Song JD. Shi Yan Sheng Wu Xue Bao; 2000 Mar 01; 33(1):21-6. PubMed ID: 12548848 [Abstract] [Full Text] [Related]
19. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells. Tan X, Egami H, Nozawa F, Abe M, Baba H. Int J Oncol; 2006 Feb 01; 28(2):369-74. PubMed ID: 16391791 [Abstract] [Full Text] [Related]
20. Thrombospondin-1 up-regulates tumor cell invasion through the urokinase plasminogen activator receptor in head and neck cancer cells. Albo D, Tuszynski GP. J Surg Res; 2004 Jul 01; 120(1):21-6. PubMed ID: 15172186 [Abstract] [Full Text] [Related] Page: [Next] [New Search]